(NYSE: CBT) Cabot's forecast annual revenue growth rate of 2.5% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Cabot's revenue in 2026 is $3,575,000,000.On average, 7 Wall Street analysts forecast CBT's revenue for 2026 to be $186,921,150,957, with the lowest CBT revenue forecast at $178,042,267,233, and the highest CBT revenue forecast at $199,723,262,373. On average, 7 Wall Street analysts forecast CBT's revenue for 2027 to be $192,083,292,657, with the lowest CBT revenue forecast at $180,365,230,998, and the highest CBT revenue forecast at $204,678,918,405.
In 2028, CBT is forecast to generate $199,000,562,535 in revenue, with the lowest revenue forecast at $186,869,529,540 and the highest revenue forecast at $213,299,695,044.